Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Medtronic
Chubb
Deloitte
Accenture

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 8,663,194

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,663,194
Title:Intraocular drug delivery device and associated methods
Abstract: The present invention provides devices, systems, and methods for delivery of an active agent into the eye of a subject. In one aspect, for example, an ocular active agent delivery device (10) can include an active agent reservoir (14) disposed in an annular housing (12), the annular housing (12) being configured to fit inside of a lens capsule and at least partially encircling a line of sight of an intraocular lens within the lens capsule. The device (10) can further include a semipermeable membrane (16) operatively coupled to the active agent reservoir (14), where the semipermeable membrane (16) is configured to allow diffusion of an active agent from the active agent reservoir (14). Additionally, a valve (18) can be operatively coupled to the active agent reservoir (14), where the valve (18) is configured to allow filling of the active agent reservoir (14) with an active agent.
Inventor(s): Ambati; Balamurali K. (Sandy, UT), Gale; Bruce K. (Taylorsville, UT)
Assignee: University of Utah Research Foundation (Salt Lake City, UT)
Application Number:12/945,428
Patent Claims:see list of patent claims

Details for Patent 8,663,194

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30 ➤ Sign Up University of Utah Research Foundation (Salt Lake City, UT) 2028-05-12 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up University of Utah Research Foundation (Salt Lake City, UT) 2028-05-12 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up University of Utah Research Foundation (Salt Lake City, UT) 2028-05-12 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,663,194

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2009140246 Apr 01, 2010
World Intellectual Property Organization (WIPO) 2009140246 Nov 19, 2009
World Intellectual Property Organization (WIPO) 2018125930 Jul 05, 2018
United States of America 10064819 Sep 04, 2018
United States of America 2011282328 Nov 17, 2011
United States of America 2012089113 Apr 12, 2012
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Chinese Patent Office
Daiichi Sankyo
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.